Ipilimumab vs Methylprednisolone
Ipilimumab vs Methylprednisolone: Overview
This comparison examines the pharmacological differences between Ipilimumab and Methylprednisolone.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Methylprednisolone: Intermediate-acting synthetic glucocorticoid.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Methylprednisolone β 18-36 hours.
Chemical Properties
Molecular Formula: Methylprednisolone β C22H30O5.
Molecular Weight: Methylprednisolone β 374.4710 g/mol.
Type: Ipilimumab β Antibody; Methylprednisolone β Small molecule.